Stroma is an eye aesthetics company focused on safely and effectively changing eye color. The company uses a proprietary non-surgically invasive system that will create option for patients, and opportunities for physicians doing the procedure. Stroma is a clinical phase medical device company located in Irvine CA. The company's mission is to be the leader in the design, development and distribution of a comprehensive system to safely and effectively change the color of people's eyes. The company's patented system changes the colors from dark, brown, black and hazel, to light blue or green. Creating the option for people who are currently wearing colored contact lens (25 million people worldwide) to change their eye color to a natural looking color without the hassle of colored contacts or dangers of an iris implant. The Stroma Laser System includes a laser, eye mapping, and eye tracking system to photo disrupt the pigment in the front of the iris and create a situation where the body is able to eliminate the pigment safely without causing damage to the surrounding nerves and tissue. The company has successfully completed its initial scientific, animal and human testing and is now moving towards a formal clinical trial process. The company intends to market the technology outside the US initially when it has successfully completed its regulatory filings. The market for the company's technology represents a $2.9B opportunity and the company intends to market their products to ophthalmic surgeons and consumers worldwide. The company has assembled a great team of experienced medical device professionals to run the company. Leading optical, laser, and software engineers to complete the development. And, leading ophthalmic surgeons to advise the company on all clinical aspects of the company's system. All of these factors provide for an excellent opportunity for investors interested in optimizing their ROI through a positive exit either through a major strategic player in the ophthalmic space or via an IPO.